FDA Approves Stem Cell Trial For ALS Treatment
The U.S. Food and Drug Administration gave the green light Friday for a clinical trial of a new stem cell treatment for amyotrophic lateral sclerosis (ALS). University Michigan neurologist, Eva Feldman, M.D., Ph.D., will be the overall principal …
[Read the full article here]Related News:
Stem cell trial for ALS treatment gets FDA OK
University of Michigan neurologist leading stem cell trial for ALS treatment
FDA approves Neuralstem's IND for commencing a stem cell trial to treat Amyotrophic Lateral Sclerosis